Global Trade Alert
Global Trade Alert

Back to state act

United States of America: Agreement with Sanofi on Most-Favoured-Nation drug pricing and tariff exemption

Description

On 19 December 2025, the United States announced an agreement with Sanofi providing the company with a three-year period free from Section 232 tariffs. In exchange, Sanofi agreed to implement most-fav...

Sign in to see full description

Intervention Details

Intervention Type

Import tariff

MAST Chapter

I: Trade-related investment measures

Implementation date

No implementation date

Revocation date

No revocation date

Implementation level

National

Affected flow

Inward

Announced as temporary

No

Eligible firms

firm-specific

Affected Trading Partners

Graph

Table

Affected Sectors

Sign in to access 1 sectors

Affected Products

Sign in to access 5 products

Threads

See all

This intervention is not part of any Thread yet.